Unique approach

While each of the PharmaFutures initiatives is distinct, the common thread is the investor-led discussion focused on identifying long-term value creation opportunities that will yield enhanced public health outcomes. The project approach began with a scenario-planning exercise and has increasingly become more granular, exploring key value drivers for the pharmaceutical industry and identifying potential new models for expanding access to healthcare in emerging markets, including China, Brazil and India.

Visit these links to learn more about PharmaFutures’ unique approach:

Comments

Innovation remains core to our success, ensuring we research and develop new medicines and vaccines which address unmet medical needs. The Shared Value report outlines how all stakeholders including industry, investors, governments and regulators can play their part in ensuring the appropriate balance between value for money and delivering fair rewards for innovation can be achieved.

Simon Jose, GSK